Nordic American Tankers Ltd. (0UC0)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 7.350 |
|---|---|
| 52-week range | 3.277 – 8.930 |
| Return, 1 month / 3 months | −9.8% / +13.6% |
| Return, 1 year / 3 years | +115.2% / +140.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 41.8% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 0.24M USD |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nordic American Tankers owns and operates a fleet of Suezmax crude oil tankers. The company charters these vessels to oil companies and trading houses that move crude oil by sea, mainly on spot voyages and period charters. It is incorporated in Bermuda and runs its commercial operations from Norway, with its ships trading on international routes. The business depends on tanker freight rates and the demand for seaborne crude oil transport.
On this site Nordic American Tankers Ltd. appears as a stock on the London Exchange (UK), code 0UC0, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nordic American Tankers Ltd. (0UC0) trades on the London Exchange in UK. It last closed at USD 7.350 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 752 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 115.2% and over the last three months it rose 13.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.0% | ||
| From 52-week high | -16.7% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.6% | ||
| 6-month return | 30.6% | ||
| 12-month return, skipping the last month | 138.6% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.24M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −16.7% |
|---|---|
| 1 month | −9.8% |
| 3 months | +13.6% |
| 6 months | +30.6% |
| 1 year | +115.2% |
| 3 years | +140.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.498 / 5.928 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.434 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Dec 2025 | USD 0.1300 |
| 12 Sep 2025 | USD 0.1000 |
| 12 Jun 2025 | USD 0.0700 |
| 10 Mar 2025 | USD 0.0600 |
| 17 Dec 2024 | USD 0.0400 |
| 26 Sep 2024 | USD 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.